134 related articles for article (PubMed ID: 1975333)
1. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates.
Perez-Schael I; Blanco M; Garcia D; White L; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ; Flores J
J Med Virol; 1994 Apr; 42(4):330-7. PubMed ID: 8046423
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
[TBL] [Abstract][Full Text] [Related]
4. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
[TBL] [Abstract][Full Text] [Related]
5. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
[TBL] [Abstract][Full Text] [Related]
6. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.
Vesikari T; Ruuska T; Koivu HP; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1991 Dec; 10(12):912-7. PubMed ID: 1662796
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
[TBL] [Abstract][Full Text] [Related]
9. Tetravalent rhesus rotavirus vaccine in young infants.
Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
Midthun K; Halsey NA; Jett-Goheen M; Clements ML; Steinhoff M; King JC; Karron R; Wilson M; Burns B; Perkis V
J Infect Dis; 1991 Oct; 164(4):792-6. PubMed ID: 1654365
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
12. Field trial of rhesus rotavirus vaccine in infants.
Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
14. Review of rotavirus vaccine trials in Finland.
Vesikari T; Joensuu J
J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
16. Neonatal administration of rhesus rotavirus tetravalent vaccine.
Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
19. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
Rennels MB; Losonsky GA; Shindledecker CL; Hughes TP; Kapikian AZ; Levine MM
Pediatr Infect Dis J; 1987 Mar; 6(3):260-4. PubMed ID: 3033593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
